Brief: Poxel Publishes Two Preclinical Articles On X-Linked Adrenoleukodystrophy
July 5 (Reuters) - Poxel SA POXEL.PA :
* POXEL ANNOUNCES THE PUBLICATION OF TWO PRECLINICAL
ARTICLES ON
X-LINKED ADRENOLEUKODYSTROPHY FOR PXL065 AND PXL770
* BOTH COMPOUNDS ARE PREPARING TO ENTER INTO PHASE 2A
CLINICAL
PROOF-OF-CONCEPT (POC) BIOMARKER STUDIES IN ALD PATIENTS WITH
ADRENOMYELONEUROPATHY (AMN) AS SOON AS POSSIBLE, SUBJECT TO
FINANCING
Source text for Eikon: ID:nBw14wQxpa
Further company coverage: POXEL.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Poxel SA
See all newsFrance's Poxel Q3 revenue rises on higher TWYMEEG royalties
France's Poxel Q2 revenue rises on higher TWYMEEG royalties
France's Poxel Q1 revenue rises 20% on TWYMEEG sales
Brief: Poxel Announces That A Combined General Meeting Will Be Held On December 11, 2025 And The Availability Of The Preparatory Documents
Brief: Poxel Says Cash Runway Estimated Between Mid To End Q2 2025